Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8403280 | 0.87 | KIF11 (0.48) | KIF11KCNH2CA4LTA4HLMNA | |
| SCHEMBL14937220 | 0.85 | KIF11 (0.46) | KIF11KCNH2CA4LTA4HLMNA | |
| SCHEMBL9559237 | 0.84 | KIF11 (0.51) | KIF11KCNH2CA4LTA4HLMNA | |
| SCHEMBL6129866 | 0.83 | KIF11 (0.50) | KIF11KCNH2LTA4HLMNAHTT | |
| SCHEMBL10586379 | 0.83 | KIF11 (0.54) | KIF11KCNH2SMN1; SMN2 | |
| SCHEMBL4579061 | 0.82 | KIF11 (0.44) | KIF11KCNH2LTA4HLMNAHTT | |
| SCHEMBL8734433 | 0.82 | KIF11 (0.44) | KIF11KCNH2LTA4HLMNAHTT | |
| SCHEMBL7747362 | 0.82 | KIF11 (0.44) | KIF11KCNH2LTA4HLMNAHTT | |
| SCHEMBL8587190 | 0.81 | KDM4E (0.43) | KIF11KCNH2LMNASMN1; SMN2KMT2A | |
| SCHEMBL15517407 | 0.81 | KIF11 (0.56) | KIF11KCNH2CA4LTA4HLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2111218-B1 | DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES | UNIV SYDDANSK (DK) | 2014-07-02 | — | — | EP | disclosed |
| US-20100144848-A1 | DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES | SYDDANSK UNIVERSITET (DK) | 2010-06-10 | — | — | US | disclosed |
| EP-2111218-A1 | DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES | Syddansk Universitet (DK) | 2009-10-28 | — | — | EP | disclosed |
| WO-2008089771-A1 | DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES | SYDDANSK UNIVERSITET (DK) | 2008-07-31 | — | — | WO | disclosed |
| US-6008398-A | Non-nucleotide phosphorus ester oligomers | GENZYME CORPORATION (US) | 1999-12-28 | — | — | US | disclosed |
| US-5919965-A | Non-nucleotide phosphorus ester oligomers | GENZYME CORPORATION (US) | 1999-07-06 | — | — | US | disclosed |
| EP-0880532-A4 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0880532-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0804443-A4 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS INC (US) | 1998-04-29 | — | — | EP | disclosed |
| EP-0804443-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1997028168-A1 | NON-NUCLEOTIDE PHOSPHOROUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1997-08-07 | — | — | WO | disclosed |
| WO-1996022297-A9 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | — | 1996-10-03 | — | — | WO | disclosed |
| WO-1996022297-A1 | NON-NUCLEOTIDE PHOSPHORUS ESTER OLIGOMERS | PHARMAGENICS, INC. (US) | 1996-07-25 | — | — | WO | disclosed |